The use of Knowledge Graph based DTI (KG-DTI) to reposition medications for Alzheimer's disease (AD) by targeting apolipoprotein E shows potential and the top-recommended medications gives experimental proof that it may be repositioned to treat AD. Here, APOE is linked to Alzheimer disease.